Ganeden publishes product, prebiotics study in Anaerobe
Peer-reviewed work focuses on use of GanedenBC30 with prebiotics
Ganeden Biotech, a manufacturer and marketer of probiotics, has published its nineteenth peer-reviewed study in Anaerobe (The Official Journal of the Anaerobe Society of the Americas). The study, conducted by Dr. Glenn Gibson, professor at the University of Reading, England; in their validated intestinal model, demonstrated that there are benefits to taking GanedenBC30 and prebiotics together versus taking prebiotics alone, according to the company.
Prebiotics have been shown to increase healthy bacterial species such as lactobacilli and bifidobacteria. In the study, bacterial flora changes were analyzed with prebiotics alone as well as with prebiotics plus GanedenBC30. While there were increases in lactobacilli and bifidobacteria in both cases, there were additional increases in other good bacterial strains (such as Faecalibacterium prausnitzii, an important bacteria for intestinal health) when consumed along with GanedenBC30. In addition, prebiotic activity was increased when consumed with GanedenBC30 as measured by an increase in short chain fatty acids, which are important components for intestinal health.
“This study is exciting, as it lays the groundwork for continuing our research into the combined benefits of GanedenBC30 and prebiotics,” said David Keller, vice president of scientific operations at Ganeden Biotech. “We are well aware of both the benefits of GanedenBC30 and the benefits of prebiotics separately, but now we have data showing increased digestive benefits of consuming them together.”